UNCY Smart Money
Unicycive Therapeutics, Inc.
1W: -5.0%
1M: -22.2%
3M: -23.8%
YTD: -37.8%
1Y: -29.6%
3Y: -58.5%
5Y: -85.8%
$3.61
+0.03 (+0.84%)
Weekly Expected Move ±8.7%
$3
$4
$4
$4
$5
Credit Risk of going bust: lower than 62% of companies Debt: 0.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down 99.9%), Unicycive Therapeutics, Inc. would be worth roughly what it owes.
Total debt $671K against a stock market value of $98.9M.
Distance to default 6.39 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $336K (short-term plus half of long-term), stock volatility 84.4%; Altman Z'' -1.95. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down 99.9%), Unicycive Therapeutics, Inc. would be worth roughly what it owes.
Total debt $671K against a stock market value of $98.9M.
Distance to default 6.39 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $336K (short-term plus half of long-term), stock volatility 84.4%; Altman Z'' -1.95. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 202688
Institutions Holding
+34 vs prior
55.3%
Ownership
-10.60%
37
New
22
Increased
19
Reduced
7
Closed
👔 Insider Trades
1 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025-08-25 | Aggarwal Gaurav | director | C-Conversion | 652,900 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,413,381 | $7M | +1,377,478 | 2026-06-30 | Filing |
| Nantahala Capital Management, LLC | 1,401,447 | $7M | +462,245 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,071,481 | $5M | +260,051 | 2026-06-30 | Filing |
| Octagon Capital Advisors LP | 1,000,000 | $5M | — | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 564,019 | $3M | +360,275 | 2026-06-30 | Filing |
| Vivo Capital, LLC | 550,000 | $3M | -1,239,916 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 547,862 | $3M | +392,924 | 2026-06-30 | Filing |
| Logos Global Management LP | 473,563 | $2M | — | 2026-06-30 | Filing |
| STATE STREET CORP | 450,162 | $2M | +370,135 | 2026-06-30 | Filing |
| Diametric Capital, LP | 374,132 | $2M | +293,770 | 2026-06-30 | Filing |
| J. Goldman & Co LP | 327,345 | $2M | +327,345 | 2026-06-30 | Filing |
| DIADEMA PARTNERS LP | 303,676 | $1M | +197,593 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 271,456 | $1M | -1,127,892 | 2026-06-30 | Filing |
| Dauntless Investment Group, LLC | 214,000 | $1M | +66,913 | 2026-06-30 | Filing |
| CITIGROUP INC | 182,654 | $857K | +182,653 | 2026-06-30 | Filing |
| NORTHERN TRUST CORP | 181,930 | $853K | +145,993 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 169,196 | $794K | +169,196 | 2026-06-30 | Filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 160,039 | $751K | -39,180 | 2026-06-30 | Filing |
| Jump Financial, LLC | 153,000 | $718K | +153,000 | 2026-06-30 | Filing |
| VANGUARD FIDUCIARY TRUST CO | 148,965 | $699K | +47,891 | 2026-06-30 | Filing |